Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enarodustat Plus CsA Versus CsA Monotherapy in Newly-diagnosed TD-NSAA
NCT07522996Phase 3Withdrawn
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jun 2026
- Primary completion
- Dec 2028
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of enarodustat in aplastic anemia, sponsored by Peking Union Medical College Hospital. Planned start Jun 2026; status: withdrawn.
02
Drugs
enarodustat
03
Conditions
aplastic anemia
Beyond the preview
Go deeper on NCT07522996.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07522996.